Adamas Pharmaceuticals
ADMS
#7889
Rank
C$0.53 B
Marketcap
C$11.79
Share price
0.00%
Change (1 day)
16,619.81%
Change (1 year)

Earnings for Adamas Pharmaceuticals (ADMS)

Earnings in 2021 (TTM): -C$48.73 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current earnings are C$88.18 Million. In 2020 the company made an earning of -C$62.91 Million, an increase over its 2019 earnings that were of -C$0.13 Billion.

Earnings history for Adamas Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-C$48.73 Million-22.54%
2020-C$62.91 Million-51.34%
2019-C$0.13 Billion-19.45%
2018-C$0.17 Billion28.96%
2017-C$0.13 Billion42.3%
2016-C$87.46 Million6.18%
2015-C$82.38 Million-410.24%
2014C$26.55 M-67.53%
2013C$81.76 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
C$18.37 B-33,271.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.64 B-17,504.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$10.26 B-18,620.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-C$0.31 Billion 448.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Supernus Pharmaceuticals
SUPN
-C$51.91 Million-6.31%๐Ÿ‡บ๐Ÿ‡ธ USA